Overall U.S. hospital employment hit 5,223,000 in March, rising 2.11% over the 5,115,000 recorded in March of 2018, according to the latest numbers from the Bureau of Labor Statistics.

Ablacon, a Colorado-based company leveraging AI to develop an advanced mapping system to aid in the treatment of atrial fibrillation, has raised $21.5 million in a Series A funding round, the company announced.

Healthcare technology moves at lightning speed, with AI and machine learning at the forefront of innovation. Right alongside these new discoveries is blockchain technology, which was popularized through the rise of cryptocurrency, and is seeing its own emergence in healthcare.

Nearly a quarter of CT pulmonary angiography (CTPA) orders did not align with scoring system guidelines for evaluating potential pulmonary embolism (PE) in the emergency department, according to a single-center study published in the Journal of the American College of Radiology.

Stress disorders like PTSD and adjustment disorder were linked to adverse cardiovascular outcomes in a recent BMJ study, Reuters reports, with the greatest CV risk posed in the months directly after a patient is diagnosed with such a condition.

The FDA has released a new draft guidance focused on the completion of premarket submissions for medical devices with quantitative imaging functions.

A little over a year ago, California’s insurance commissioner began investigating Aetna for possibly denying care coverage without reviewing the records of a patient who’d filed a lawsuit. Now the company has agreed to an out-of-court settlement.

The FDA has expanded Praluent’s (alirocumab) regulatory approval to reflect the reduced risk of heart attack, stroke and unstable angina evidenced in 2018’s ODYSSEY OUTCOMES trial—a move announced the same day drugmaker Sanofi released its first-quarter earnings, which were lower than expected.

Healthcare is a major voter issue, but many Americans tend to trust Democrats more than Republicans in this area heading into the 2020 election, according to a new poll from the Associated Press-NORC Center for Public Affairs Research.

Supplementing standard physicals with Abbott’s high-sensitivity troponin-I blood test could boost the accuracy of CVD prediction in middle-aged patients, according to research published in Circulation April 29.